Pharmaceutical News and Articles

Newer Epilepsy Medications Used During Pregnancy Do Not Affect Neurological Development in Children

Children of mothers who took certain antiseizure medications while pregnant do not have worse neurodevelopmental outcomes at age 6, according to a long-running

Applied Therapeutics Receives Complete Response Letter from U.S. FDA Regarding New Drug Application for Govorestat for Classic Galactosemia

Newer Epilepsy Meds Safe During Pregnancy, Won't Affect Kids' Neurodevelopment

For decades, it s been known that certain older medications women use to control epilepsy seizures can pose risks to a fetus. However, data now suggests that no

Switch From Animal to Plant Proteins Greatly Boosts Heart Health

Moving away from meat to plants as a main source of protein will do wonders for your heart, new research finds. The 30-year study found that folks with the high

Workers Who Make Kitchen Countertops Face Big Lung Hazards

The workers who cut and finished your sleek stone countertop may be paying a price in poor lung health, new research shows. Breathing in dust created by the man

Antibiotics or Surgery: What's Best for Child Appendicitis?

For decades, surgery to remove an inflamed appendix has been a rite of childhood for many. But a new study says treating appendicitis with antibiotics, rather t

Salmonella Outbreak Triggers Recall of Cucumbers in 26 States

Sixty-eight people have been sickened and 18 have been hospitalized in a salmonella outbreak linked to whole cucumbers sold in 26 states and parts of Canada. Ep

Discontinuing Cholinesterase When Starting Memantine Not Tied to Institutionalization Care

Discontinuing cholinesterase inhibitors upon memantine initiation is not associated with an increased risk for long-term care institutionalization among older a

Guidelines Developed for Treatment of Restless Legs Syndrome

In a clinical practice guideline issued by the American Academy of Sleep Medicine and published online Sept. 26 in the Journal of Clinical Sleep Medicine, recom

Considerable Scale-Up Needed to Achieve 2025 Goals for HIV PrEP

Considerable scale-up is needed to achieve the 2025 goals for HIV preexposure prophylaxis (PrEP), according to research published in the Nov. 28 issue of the U.